Summary
Anirudh Jayanti is a Manager in the Life Sciences Practice. Dr. Jayanti specializes in applying economic and statistical analysis to life sciences and healthcare matters, particularly as related to antitrust issues. His experience includes pharmaceutical and healthcare matters involving monopolization, false marketing, patent disputes, and reimbursement disputes. In these matters, Dr. Jayanti has analyzed market power, market definition, competitive effects, causation, and damages. He has supported testifying experts and provided consulting support to clients through all phases of litigation.
Education
PhD, Economics, University of Michigan
MA, Economics, University of Michigan
AB, Economics and Mathematics, Dartmouth College
Practices
Selected Work
Selected Experience
- Provided consulting expertise and led the team supporting the testifying expert on behalf of the pharmaceutical manufacturer defendant in a monopolization case.
- Led the team supporting the expert on damages on behalf of a pharmaceutical manufacturer defendant concerning allegations of inappropriate marketing leading to lost profits for plaintiff hospitals.
- Supported the testifying expert on issues of market definition and market power on behalf of the pharmaceutical manufacturer defendant in connection with antitrust allegations of delayed generic entry.
- Supported the testifying expert on causation on behalf of a manufacturer defendant concerning allegations of inappropriate marketing of prescription opioids.
- In Sandoz Inc. and Raregen, LLC v. United Therapeutics Corporation and Smiths Medical ASD, Inc., provided support for the expert report of Dr. Eric Gaier regarding issues of market definition, market power, and competitive effects on behalf of United Therapeutics and Smiths Medical in connection with plaintiffs’ allegations of exclusionary contracts in violation of antitrust laws.
- In Veeva Systems Inc.v. IQVIA Inc. and IMS Software Services, Ltd., supported the expert on behalf of Veeva assessing alleged anticompetitive conduct by IQVIA concerning monopolization of data and data management software for pharmaceutical companies.
- Supported the expert in two related intellectual property matters on behalf of a pharmaceutical manufacturer alleging infringement of patents on its brand-name drug against a generic manufacturer.
- In In re Determination of Rates and Terms for Making and Distributing Phonorecords, supported the expert in preparing testimony on behalf of Spotify USA Inc. regarding royalty payments under Section 115 of the Copyright Act.